Sangamo Therapeutics, Inc.
看多

SGMO Last Correction before the rally

389
After Roche partnered with SGMO for the Tau Alzheimer program ,
BIIB was so in anger Sangamo didnt want to give them another chance ,
they dumped almost all their remaining SGMO shares .

BIIB dumped 11.4 M shares into OPEX week

Now the stock is going down.( Worse than expected earnings trigger )

There is a big buying opportunity around 0.60 $

Note: Goldman increased their positions 10X

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。